40 Hz vibrations reduce Alzheimer’s pathology, symptoms in mouse models May 18, 2023 … sensory stimulation and an MIT spin-off company, Cognito Therapeutics, has launched stage III clinical trials of light …
Colloquium on the Brain and Cognition with Michelle Monje, MD, PhD, Stanford University … research program has advanced preclinical studies of novel therapeutics for pediatric high-grade gliomas and cancer …
Study pinpoints Alzheimer’s plaque emergence early and deep in the brain October 04, 2019 … This will in turn facilitate the development of effective therapeutics.” Amyloid's march in the Alzheimer's mouse …
Arbaclofen for Fragile X … children. With the sponsorship of startup company Seaside Therapeutics, the approach reached stage III clinical trials …
